Evidence map›Paper›PMID 38216552›Full record

ArticleBiochemistry2024

Differences in Oligomerization of the SARS-CoV-2 Envelope Protein, Poliovirus VP4, and HIV Vpu.

Julia A Townsend, Oluwaseun Fapohunda, Zhihan Wang, Hieu Pham, Michael T Taylor, Brian Kloss, Sang Ho Park, Stanley Opella, Craig A Aspinwall, Michael T Marty

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Julia A TownsendDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.
Oluwaseun FapohundaDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.ORCID 0000-0001-6545-3471
Zhihan WangDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.
Hieu PhamDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.ORCID 0009-0000-5542-6357
Michael T TaylorDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.ORCID 0000-0002-7655-7222
Brian KlossNew York Consortium on Membrane Protein Structure, New York Structural Biology Center, New York, New York 10027, United States.
Sang Ho ParkDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.ORCID 0000-0003-2973-7156
Stanley OpellaDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.
Craig A AspinwallDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.ORCID 0000-0002-4359-5812
Michael T MartyDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.ORCID 0000-0001-8115-1772
University of Arizona · USUniversity of California San Diego · USNew York Structural Biology Center · US

Funding

Training (303-338)P41GM116799 · NIGMS · NEW YORK STRUCTURAL BIOLOGY CENTER · PI HENDRICKSON, WAYNE A. · 2016 to 2020
$7.1M
CHEMISTRY-BIOLOGY INTERFACE TRAINING PROGRAMT32GM008804 · NIGMS · UNIVERSITY OF ARIZONA · PI MONTFORT, WILLIAM R. · 2003 to 2023
$3.9M
Unravelling Membrane Protein-Lipid Interactions using Nanodiscs and Mass SpectrometryR35GM128624 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI Michael T Marty · 2018 to 2026
$3.6M
Structures, Dynamics, and Functions of Membrane ProteinsR35GM122501 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OPELLA, STANLEY J · 2017 to 2021
$2.5M
New Chemical Tools for Optically Controlled Protein ModificationR35GM143120 · NIGMS · UNIVERSITY OF WYOMING · PI TAYLOR, MICHAEL T · 2021 to 2025
$1.6M
NIGMS NIH HHS P41 GM116799NIGMS NIH HHS R35 GM122501NIGMS NIH HHS R35 GM128624NIGMS NIH HHS R35 GM143120NIGMS NIH HHS T32 GM008804
6 · The paper itself

Abstract

Viroporins constitute a class of viral membrane proteins with diverse roles in the viral life cycle. They can self-assemble and form pores within the bilayer that transport substrates, such as ions and genetic material, that are critical to the viral infection cycle. However, there is little known about the oligomeric state of most viroporins. Here, we use native mass spectrometry in detergent micelles to uncover the patterns of oligomerization of the full-length SARS-CoV-2 envelope (E) protein, poliovirus VP4, and HIV Vpu. Our data suggest that the E protein is a specific dimer, VP4 is exclusively monomeric, and Vpu assembles into a polydisperse mixture of oligomers under these conditions. Overall, these results revealed the diversity in the oligomerization of viroporins, which has implications for the mechanisms of their biological functions as well as their potential as therapeutic targets.

Indexed as

COVID-19HIV InfectionsPoliovirusHuman Immunodeficiency Virus ProteinsHumansSARS-CoV-2Viral Regulatory and Accessory ProteinsViroporin ProteinsHuman Immunodeficiency Virus ProteinsViral Regulatory and Accessory ProteinsViroporin Proteins

Identifiers

PMID38216552
PMCPMC10872257
OpenAlexW4390838187

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.